NCT06938529View on ClinicalTrials.gov

A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 18, 2025

Primary Completion Date

July 15, 2025

Study Completion Date

July 25, 2025

Conditions
Obesity, Overweight
Interventions
DRUG

VCT220

Small molecule GLP-1RA tablet, film coated

DRUG

Placebo

VCT220 Placebo tablet

Trial Locations (1)

215006

The First Affiliated Hospital of Suzhou University, Suzhou

All Listed Sponsors
lead

Vincentage Pharma Co., Ltd

INDUSTRY